Biologics can be an improvement to small molecule drugs, providing high specificity for an identified target, lowering toxicity and limiting side effects. To achieve effective delivery, the biologic must have sufficient time to reach the target tissue. A prolonged half-life in the circulating environment is desired, but often serum stability is limited by proteases. Proteolysis in the serum causes degradation and inactivation as the biologic is fragmented and more rapidly cleared from the body. To improve the circulating half-life, large, hydrophilic polymers may be conjugated or stable fusion tags may be engineered to increase the effective size of the peptide and to hinder degradation by proteases. Improved resistance to proteases is essential for effective delivery. Here, a proof of concept study is presented using a metal-binding tripeptide tag known as the claMP Tag to create an inline conjugate and the ability of the tag to inhibit proteolysis was examined.
Introduction
The specificity provided by a biologic for a target of interest enables delivery of highly potent molecules with fewer side effects (Thundimadathil, 2012; Fosgerau and Hoffmann, 2015; Srinivasarao et al., 2015) . Active pharmaceutical ingredients or chelating agents can be conjugated to polypeptides to achieve targeted delivery in therapeutic and diagnostic applications. For effective delivery, the intact conjugate must have an adequate amount of time to accumulate in the target tissue (Carter and Senter, 2008; Hamley, 2014) . Designing a biologic to remain intact until it reaches the target site is difficult because enzymatic degradation processes are capable of rapid proteolytic degradation (Bruno et al., 2013; Craik et al., 2013; Mitragotri et al., 2014) . Peptides often succumb to short circulation half-lives, either due to their small size, being filtered and removed promptly by the kidney, or proteolytic degradation, rendering them unable to act at their target site (Daugherty and Mrsny, 2006; Werle and Bernkop-Schnürch, 2006; Torchilin, 2008) , such as with the peptide glucagon-like peptide-1 (GLP-1) leading to the development of Exenatide™ (Pratley and Gilbert, 2008 ). An appropriate amount of time is necessary for the targeting molecule and its payload to reach the target in both therapeutic and imaging applications where accumulation at the target site is necessary for effective treatment and high-resolution imaging results (Bae and Park, 2011; Kwon et al., 2012) .
The half-life of a small biologic is optimized by increasing the time the biologic has to reach the target site and is routinely accomplished by chemical modifications that increase size, slowing filtration and reducing access by proteases to cleavage sites (Pollaro and Heinis, 2010) . Synthetic hydrophilic polymers such as polyethylene glycol (PEG) increase the circulation half-life and solubility as well as decrease proteolysis, demonstrated by PegIntron™ (Schering-Plough) (Kozlowski and Milton Harris, 2001; Chapman, 2002; Harris and Chess, 2003) . PEG is a non-metabolized, synthetic compound, and a better tolerated and biodegradable partner is preferable (Mitragotri et al., 2014; Strohl, 2015) . Genetic incorporation of an amino acid polymer, known as XTEN, consisting of a sequence of hydrophilic, stable residues creates an inline, homogeneous half-life enhanced molecule (Schellenberger et al., 2009) . Used as an alternative to PEG, XTEN is practical to encode biosynthetically and, while resistant to serum proteases, is biodegradable (Haeckel et al., 2014) . Conjugation of 288 amino acids of XTEN to the hormone glucagon (Gcg) increased the half-life from 10 min to 9 h (Geething et al., 2010) and XTEN addition to both termini of recombinant human growth hormone (rhGH) to produce Somavaratan (VRS-317) yields a 30-60-fold increase in plasma half-life, potentially enabling once monthly dosing instead of daily injection (Moore et al., 2016) . Increasing half-life by enlarging size, however, results in longer exposure time to proteases. Resistance to proteases through strategic engineering is important for combating loss through enzymatic degradation and, while amino acid tags used to increase the serum stability of peptides are being developed, none have been consistently reliable and a method to inhibit proteases across a broad range of peptides is still sought (Jambunathan and Galande, 2014) .
The need to extend the half-life of peptides is particularly important when they are used as imaging agents (Lee et al., 2010; Pollaro and Heinis, 2010) . Peptides conjugated to a chelator generate contrast agents for imaging applications to visualize tumors for diagnosis. For example, Sandostatin™ (Novartis Pharmaceuticals), a somatostatin analog, improved the half-life of somatostatin from 2 min to 90 min and when radiolabeled creates a conjugate capable of effectively imaging carcinoid tumors (Critchley, 1997) . In applications involving metals, circulating half-life is typically short because dilution into the large volume of a patient leads to rapid loss of the metal from the carrier via transmetallation reactions (Cacheris et al., 1990; Frenzel et al., 2008) . When metal is lost from the chelator prematurely, free metal ions accumulate in the bone and liver causing changes to normal cellular processes, toxicity and elevated background signal, decreasing the quality of the image (Morawski et al., 2005; Ersoy and Rybicki, 2007; Sieber et al., 2008; Aime and Caravan, 2009) . Lanthanides are used currently because available chelators are poorly compatible with small transition metals, but small transition metals are preferred because of their biocompatibility and decreased patient toxicity (Franz et al., 2003; Yang et al., 2008 ). An alternative method for delivery of metals to a target site for imaging is to use the novel metal-binding tripeptide known as the claMP Tag (Krause et al., 2010 (Krause et al., , 2011 (Krause et al., , 2013 . The claMP Tag has the capability of acting as a contrast agent by binding safe, biocompatible transition metals rather than large, toxic lanthanide ions. Our lab discovered the unique metal abstraction peptide (MAP) chemistry and developed the inline claMP Tag, which is currently being investigated as a targeted delivery method of transition metals for therapeutic and diagnostic applications. The tag consists of the amino acid sequence Asn-Cys-Cys and binds transition metals extraordinarily tightly (Laurence et al., 2012; Mills et al., 2014; Mills and Laurence, 2015) , making it possible to increase effective circulation time and target-specific tissue accumulation for transition metal-based imaging agents. The metal-claMP complex has been shown to not disrupt the overall protein structure, including proteins that depend on formation of multiple, complex disulfide bonds for proper folding and function (Mills et al., 2014; Mills and Laurence, 2015) . To investigate susceptibility of the metal-bound claMP Tag to proteolytic cleavage and determine viability of using this tag in targeted imaging applications, an in vitro proof of concept study of a fusion protein was carried out by engineering the claMP Tag adjacent to a known recognition site for the serum protease Factor Xa. A series of spacer residues were added between the protease binding motif and the tag to examine further the ability of the claMP Tag to affect cleavage at the recognition site.
Materials and Methods

Genetic engineering
Six constructs of claMP-maltose binding protein (MBP) were prepared. Five of the DNA sequences contained the claMP Tag (NCC) each with an increasing number of glycine residues on the N-terminus, from zero to four. In addition, a control was generated in which cysteine residues were replaced by alanine to eliminate metal binding (Table I) . To create the recombinant DNA, a plasmid containing MBP in the pMAL-C5X vector was obtained (New England Biolabs, Inc.) and the MBP sequence was amplified with the different N-terminal primers (Integrated DNA Technologies) using PCR. The primers consisted of a region matching the pET-32Xa/LIC vector shown as underlined, followed by the glycine spacers and claMP Tag sequence, and lastly a portion matching the N-terminal MBP sequence shown in bold (Gly4, 5′-ATT GAG GGT CGC GGA GGA GGA GGA AAC TGT TGT GGC AAA ATC GAA GAA-3′; Gly3, 5′-GGT ATT GAG GGT CGC GGA GGA GGA AAC TGT TGT GGC AAA ATC GAA GAA-3′; Gly2, 5′-GGT ATT GAG GGT CGC GGA GGA AAC TGT TGT GGC AAA ATC GAA GAA GG-3′; Gly1, 5′-GGT ATT GAG GGT CGC GGA AAC TGT TGT GGC AAA ATC GAA GAA GG-3′; Gly0, 5′-GGT ATT GAG GGT CGC AAC TGT TGT GGC AAA ATC GAA GAA GG-3′; Control, 5′-GGT ATT GAG GGT CGC AAC GCA GCA GGC AAA ATC GAA GAA GG-3′). The PCR reactions were purified using the QIAquick PCR Purification Kit (Qiagen) and the resulting product was inserted into the pET-32Xa/LIC vector via procedure provided by the manufacturer (Novagen). The ligation independent cloning reaction was then transformed into the DH5α Escherichia coli (E. coli) cell strain using the standard heat shock procedure. The cells were plated on LB agar plates with 100 μg/mL ampicillin and incubated overnight at 37°C. Colonies were individually grown in 5 mL of LB with 100 μg/mL ampicillin overnight at 37°C, 250 rpm. Cells were spun down at 4000 rpm for 15 min and the supernatant discarded. The DNA was harvested using a miniprep kit (Qiagen) and confirmed by DNA sequencing (UC Berkeley DNA Sequencing Facility).
Protein expression
Plasmids were transformed into BL21 E. coli using the standard heat shock technique. The cells were plated on LB agar plates with 100 μg/mL ampicillin and incubated overnight at 37°C. Starter cultures were prepared using a single colony to inoculate 50 mL of LB with 100 μg/mL ampicillin and grown for 16 h at 37°C, 250 rpm. About 20 mL of starter culture were used to inoculate 1 L of LB with 100 μg/mL ampicillin in a 3-L Fernbach flask. The cells were grown at 37°C, 250 rpm until the OD 600 reached approximately 0.7 and expression was induced by addition of 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). The cells were cultured for 4 h more and then harvested by centrifugation. Cell pellets were stored at −80°C until use.
Protein purification
Each 1 L pellet was resuspended in 25 mL of freshly made 50 mM Tris-Cl, 200 mM NaCl, pH 7.4 and lysed by three passes through a French press at 21 000 psi. The lysed cells were centrifuged for 1 h at 21 000 × g and 4°C. The supernatant containing the protein was filtered through a 1.2 μm filter and applied to a nickelated 5 mL HiTrap Chelating HP column (GE Lifesciences). The column was washed with 50 mM Tris-Cl, 200 mM NaCl, 40 mM imidazole, pH 7.4 for 20 CV at a flow rate of 1.25 mL/min at 4°C. The protein was eluted with 25 mL of 50 mM Tris-Cl, 200 mM NaCl, 250 mM imidazole, pH 7.4. Samples were then applied to amylose resin. Samples were diluted to 100 mL with 50 mM Tris-Cl, 100 mM NaCl, pH 8.
The eluent was applied to a 10-mL column of amylose resin (New England Biolabs, Inc.) at 1.5 mL/min using an Econo Pump (BioRad) and MBP proteins were eluted with 40 mL of 50 mM Tris-Cl, 100 mM NaCl, 10 mM Maltose, pH 8. The protein was concentrated using Amicon Ultra 30 kDa MWCO concentrators (Millipore) to a final concentration of approximately 0.5-1 mM.
Nickel release
Amylose resin was used to release the metal from the claMP Tag. Approximately 1 mL of concentrated protein was diluted to a final concentration of 10 mM EDTA, 12 mM succinate, 35 mM citrate and 70 mM NaCl, pH 6.8. This diluted the amount of maltose in the sample to approximately 0.2 mM. Protein was incubated at room temperature for approximately 2 h and either concentrated to 0.5 mM for metal quantification using absorption spectroscopy or applied to amylose resin and eluted with 30 mL of 50 mM citrate, 100 mM NaCl, 10 mM maltose, pH 6.5.
Factor Xa cleavage
Constructs were prepared in 500 μL aliquots of 0.05 mM and Factor Xa (Novagen, 0.98 mg/mL) was added to a final concentration of 0.3 nM and the reaction was carried out at room temperature and monitored for up to 12 h.
SDS-PAGE analysis
Thirty microliter aliquots of 0.05 mM protein were collected at 0, 1, 2, 4, 6, 8, 10 and 12 h, combined with 30 μL of reducing Laemmli buffer and heated at 90°C for 10 min. Samples were stored at −20°C until used. Two microliters of each gel sample was loaded onto standard 15% (v/v) resolving, 4% (v/v) stacking gels and run at 135 V for 4 h. A pre-stained molecular weight ladder was used as a reference (BioRad, #161-0374). Gels were stained with SYPRO Ruby Protein Gel Stain (Life Technologies, cat# S-12000) according to the manufacturer's instructions. Replicates were obtained by adding Factor Xa to three individual aliquots of protein at a concentration of 0.05 mM protein.
Samples of equivalent amounts of protein to reducing or non-reducing laemmli buffer were taken at every time point. SDS-PAGE was completed for each of the three replicates for each protein construct.
Densitometry analysis
The analysis was performed using a Typhoon TRIO Variable Mode Imager (Amersham Biosciences) and ImageQuant TL software (Amersham Biosciences). Relative intensity values in RFU were measured for each band and normalized to 100% for each lane in order to eliminate gel-loading variability between samples. The replicates at each time point were averaged and the time 0 point, before Factor Xa was added, was normalized to 100% intact protein. The intact fusion protein was quantified in each lane of the gel and the relative amount cleaved was determined compared to the time 0 point. Plots of the relative normalized natural log of the relative fluorescent units (RFU) over time displayed a nearly linear relationship with R 2 values displayed in Table I . The relative cleavage rate was determined from the slope and the error analysis displays a 90% confidence interval. Secondary cleavage at the thrombin recognition site was observed. The relative amount of protein cleaved at the Factor Xa recognition site was quantified as a percentage compared to the total to account for only cleavage at the site adjacent to the claMP Tag and not the minor non-specific cleavage site.
Results
SDS-PAGE and densitometry analysis to quantify proteolytic cleavage
In previous studies of claMP-tagged proteins embedded in cleavable fusion constructs, it became apparent that inclusion of the metalbound tag slowed the ability to cleave the fusion partner (Mills et al., 2014) promoting this in vitro proof of concept study to examine further how the proximity of the claMP Tag to a protease recognition site affects cleavage by a serum protease. The claMP Tag was genetically engineered into a fusion protein (Trx-claMP-MBP) adjacent to the serine protease Factor Xa recognition site between thioredoxin (Trx) and MBP (Fig. 1A) , and the extent to which the metal-bound claMP Tag inhibits the ability of Factor Xa to cleave at the adjacent site was examined. Five variants of Trx-claMP-MBP were made to examine the effect of changing the spacing between the enzymatic recognition site and the claMP Tag. Zero, one, two, three or four glycine residues were engineered between the cleavage site and the claMP Tag ( Fig. 1B and C) . A non-metal-binding control (NAA) also was made in which the two Cys in the claMP Tag were substituted with Ala. At basic pH metal is bound to the tag, kinking the protein next to the recognition site, but in acidic conditions metal is released.
SDS-PAGE was used to observe protein cleavage as a function of time and densitometry analysis was performed for quantification. The 58-kDa fusion protein is cleaved after the intended Factor Xa recognition site (Ile-Glu-Gly-Arg) into two fragments of 41 kDa (claMP-MBP) and 17 kDa (Trx) (Fig. 2) , as verified by ESI-MS. The decrease in the amount of intact fusion protein (58 kDa) over time was quantified. A linear fit was established by plotting the relative normalized natural log of the relative fluorescence units (RFUs) acquired using densitometry vs. time (Fig. 3) .
The metal-bound claMP Tag inhibits proteolysis
Ni-Gly1 was determined to inhibit Factor Xa by approximately 3-fold compared to the control at the 12-h time point showing the most inhibition compared to the other five constructs (Fig. 4) . At the 12-h time point Factor Xa cleaved 28% of the Ni-Gly1 construct whereas 83% of the control was cleaved. If Ni-claMP occludes access to the site based on steric hindrance, it would follow that the rate of cleavage would be slowest with the shortest spacer Ni-Gly0 and faster with the longest spacer Ni-Gly4. This trend was observed generally among the constructs examined except for one outlier, NiGly0. Starting with Ni-Gly1, the trend held true; Ni-Gly1 had the slowest cleavage rate and increasing the number of glycine residues in the spacer led to increasing cleavage rate with Ni-Gly3 and NiGly4 having approximately the same rate. At 12 h, 28% of Ni-Gly1, 36% of Ni-Gly2, 51% of Ni-Gly3, and 48% of Ni-Gly4 were cleaved (Fig. 4) . Surprisingly, Factor Xa cleaved more of Ni-Gly0 (54%) than even Ni-Gly4 (48%). Ni-Gly0 displayed a slower rate of cleavage than the control, suggesting the claMP module does impede access to the cleavage site, but this construct's deviation from the trend was unexpected because the protease recognition site directly abuts the Ni-claMP Tag and would be expected to more effectively hinder approach by the enzyme than the Ni-Gly1 and Ni-Gly2 variants.
Partial metal release increases proteolysis
To understand how metal bound to the claMP Tag impacts proteolysis compared to the empty claMP Tag sequence, the six constructs were subjected to mild acidic conditions in the presence of a chelating agent to release nickel form the claMP Tag and incubated with Factor Xa. The Ni-claMP Tag has spectral features in the UV and visible regions representing the unique structure of the metalbound tag with identified peak maxima at 418 nm and 530 nm ( Fig. 5 ) (Krause et al., 2013; Mills et al., 2014) . As such, UV-Vis absorption spectroscopy was used to quantify the metal remaining bound to the claMP Tag. An extensive screen of conditions and approaches was performed to identify a set of parameters under which comparable and consistent results could be achieved, culminating in the conditions reported herein. All variants shown in Fig. 5 were analyzed at equivalent protein concentration, highlighting the absorption difference when metal is bound. The absorption differences between the three constructs in the UV region are due to the Ni-bound claMP Tag absorption at 313 nm (Krause et al., 2013) .
The control protein that does not contain the claMP Tag has no absorbance in the visible region and also lacks the ligand to metal charge transfer band at 313 nm indicative of the metal-bound state, whereas these distinct features are observed with both fully occupied Ni-Gly1 and partially occupied Gly1, but in different proportions relative to the protein absorbance at 280 nm (Fig. 5) .
Results of the absorption spectroscopy revealed that metal is not released fully nor at equivalent rates and varies among the set of constructs analyzed. Consequently, it was necessary to quantify the percentage of metal retained in the claMP Tag to compare the extent of cleavage by Factor Xa among the constructs (Table II) . Metal quantification became increasingly problematic with longer incubation at pH 6.5 due to instability of the samples, which resulted in light scattering, precipitation and protein loss from solution. The amount of metal released after incubation at pH 6.5 with EDTA for 2 h was determined to be the most consistently reliable time point for measuring metal release without interferences and ranged from 46.6% to 69.4%. Most constructs released more than 57% of the Fig. 2 Factor Xa cleavage of the fusion protein, Trx-claMP-MBP, over a 24-h incubation period. Trx-claMP-MBP is cleaved at the Factor Xa recognition site into two fragments, claMP-MBP (41 kDa) and Trx (17 kDa). Trx is not shown because it is too small to be retained on the gel. The gels were stained with SYPRO Ruby Protein Gel Stain, which only allowed visualization of the 75-kDa molecular weight marker. The gel was aligned with the marker set by Coomassie staining and the ladder is shown. Fig. 3 Plot of relative cleavage of Ni-claMP Tag constructs demonstrating the inhibitory action of the inline metal-bound claMP Tag. The control, followed by Ni-Gly0 have the fastest cleavage rates as shown by the first order relative rate plot. Error bars reflect a 90% confidence interval with n = 3 data points. The R 2 values range from 0.92 to 0.99 indicating the majority of the constructs do not fit precisely to a first order linear function (Table I) . Fig. 4 The Ni-claMP Tag inhibits proteolysis relative to the control for all five constructs depicted at the 12-h time point. Ni-Gly1 exhibits the most inhibition with a 3-fold decrease in proteolysis compared to the control. Error bars represent a 90% confidence interval with n = 3 data points.
nickel from the claMP Tag, but Gly0 again was an outlier displaying greater retention of metal with only 46.6% released. Subsequent Factor Xa cleavage of the constructs demonstrates Gly1 is the most inhibitory, reducing cleavage more than 2-fold compared to the control. Gly2 and Gly3 have less impact on cleavage as additional Gly residues are placed between the enzymatic recognition sequence and the claMP Tag. In general, the percentage of apo-claMP Tag and percentage of protein cleaved increased as the number of glycine spacers was increased, with the exception of Gly0 (Fig. 6) . Gly0 is clearly an exception; this construct released appreciably less of the nickel than other constructs and yet had the greatest percentage of proteolysis. This result, however, does make sense because cleavage occurs more rapidly when metal is bound to this construct compared to the others. The data set generally suggests the metal-bound claMP Tag hinders access by the enzyme to the cleavage site, presumably because of its bulky, kinked structure. Clearly with Gly0 proteolysis is not dependent solely on metal binding to the claMP Tag because it deviates from the trend of increased proteolysis with increased number of Gly spacer residues. The study shows that cleavage by Factor Xa is dependent on the presence of the claMP Tag, its proximity to the hydrolyzed peptide bond and metal occupancy of the tag. On average, the partially metal occupied claMP Tag inhibited proteolysis approximately 2-fold, and the fully occupied Ni-claMP Tag displayed a 3-fold increase in inhibition, leading to the conclusion that the engineered sequence alone may modulate proteolysis and metal binding to the claMP Tag further impedes cleavage. The six constructs with partial metal release were compared to the nickel-bound constructs that were cleaved at pH 8. Because the rate of cleavage by Factor Xa differs between pH 6.5 and 8.0 (Qiagen and Valencia, 2003) , the relative results are compared by normalizing cleavage of the control protein at each pH to 100%. A similar trend to the fully metal-bound data set was observed (Fig. 6A) , where Gly1 exhibited the greatest inhibition, followed by Gly2, Gly3 and Gly4. In each case, a greater amount of cleavage was observed at pH 6.5 where metal release from the claMP Tag occurs. The Gly0 construct, which had 54% cleaved at pH 8, demonstrates that proteolytic susceptibility can be restored upon metal release, as evidenced by a similar amount of cleavage as the control, with 91% cleaved at 12-h (Fig. 6A) . In other samples subjected to conditions of metal release, substantial variability in the amount of protein cleaved was observed for the constructs with more Gly spacers, leading us to suspect differing degrees of instability or metal release from these molecules, possibly via metal-based crosslinking because non-reducing SDS-PAGE shows insignificant formation of intermolecular disulfide bonds between cysteine residues in the tag sequence following metal release (data not shown). Because a truly quantitative analysis of the metal-free proteins and comparison to their Ni-bound analogs would require larger amounts of pure metal-free starting materials and detailed characterization of differences in chemical and physical stability among the constructs, particularly with respect to the oxidation state of cysteine residues from the tag, herein we first demonstrate that the claMP Tag inhibits proteolysis by a serum protease, indicating subsequent more in-depth studies are warranted Because the metal is only partially released and to differing extents among the constructs and recovery of metal-free protein is poor, presumably due to instability, and in addition the enzyme cleavage rate slows as a function of time due to product formation, accurate quantitation of cleavage rate for the constructs was not feasible. As such, quantitative values reported herein are intended solely for the purpose of demonstrating relative comparisons and trends. Both the metal-bound and apo-claMP Tag constructs demonstrate a decrease in proteolytic cleavage as the spacer length is reduced from four to one glycine (Gly4 to Gly1) and that Percent protein cleaved normalized to the control at pH 6.5. c Percent metal released from the claMP Tag after incubation at pH 6.5 with EDTA at 2 h (n = 2). elimination of a spacer residue partially abrogates the inhibitory effect. The sequence, Gly1 was determined to be the most effective inhibitor of Factor Xa, decreasing cleavage rate by approximately 3-fold compared to the control. The tabulated results at pH 8 reveal a large reduction in the amount of protein cleaved compared to control when metal is bound to the claMP Tag (100% occupancy), whereas at pH 6.5, which is amenable to metal release, substantially more protein is cleaved in the same amount of time. Within each condition, the percent protein cleaved increases from Gly1 to Gly4, indicating more protein is cleaved with an increasing number of glycine residues at both pH 8 and pH 6.5. The values presented in Table I are relative (normalized to percent of control) and the ratios also are reported proportional to the amount of metal bound to permit comparison of results at the two different pH conditions. Taking the ratio of the amount of protein cleaved relative to the amount of metal bound with each construct at pH 6.5 to pH 8, it is clear substantially more protein is cleaved at pH 6.5 than pH 8 due to metal release (Fig. 6B) . The higher the ratio the greater the amount of protein cleaved at pH 6.5, when the protein is metal free, than at pH 8.
Discussion
In previous studies, it was determined that the MAP chemistry is compatible with recombinant production of difficult to express proteins having intramolecular disulfide bonds because the engineered claMP Tag does not interfere with proper folding and protein structure (Mills et al., 2014; Mills and Laurence, 2015) . In the preparation of proteins used in these studies, however, slow or incomplete cleavage of the fusion partners was observed for some constructs. Here, an in vitro proof of concept study was performed to examine how the proximity of the claMP Tag to a protease recognition site affects cleavage at the known recognition site by the serum protease Factor Xa embedded in a Trx -MBP fusion protein as a model system. The nickel-bound claMP complex has been extensively characterized, and therefore, nickel was inserted into the claMP Tag in this investigation because this metal complex has extraordinary stability and its rich spectroscopic properties enable quantitative analysis of metal incorporation (Mills et al., 2014; Mills and Laurence, 2015) . Nickel is a suitable substitute for other transition metals such as platinum and copper (unpublished data), which are sought after elements for therapeutic and diagnostic use.
When metal is bound to the tag, there is a 3-fold decrease in cleavage rate compared to the control protein. Figure 7 depicts how the metal-bound claMP Tag alters the protein's conformation and flexibility to inhibit proteolysis. When metal is not bound to the claMP Tag, the conformation of the tripeptide sequence and therefore the orientation of the two fusion proteins with respect to each other, is less restricted. In comparison, when the claMP Tag is occupied with metal, the tag becomes constrained by the obligate square planar geometry of the coordinating moieties and access to the adjacent recognition site by Factor Xa is altered, decreasing the ability to cleave the protein. In the metal-bound state, the protein sequence bends around the metal ion forming a tight turn, kinking the Fig. 6 Relative cleavage of constructs at pH 6.5 compared to pH 8. (A) The claMP Tag at pH 6.5 shows that metal release increases cleavage relative to the fully metal-bound analog at pH 8 and the control, but that cleavage remains below the level of the pH 6.5 control. Histogram represents the relative percent cleaved at 12 h normalized to the control at the same pH. Error bars reflect a 90% confidence interval with n = 3 data points. (B) Comparison of cleavage relative to the amount of metal bound to the claMP Tag. The ratios show that a substantial increase in cleavage occurs when metal is released. Fig. 7 Chemical structures indicating the site of hydrolysis by Factor Xa. Arginine is the final residue of the Factor Xa recognition site and adjacent is the claMP Tag (Asp-Cys-Cys). Arrows point to the site of peptide bond hydrolysis by Factor Xa. The claMP Tag (A) without metal bound (Gly0), (B) with metal (Ni-Gly0) and (C) with metal bound and one glycine residue (Ni-Gly1).
protein. Additional glycine residues were included in an effort to increase flexibility adjacent to the recognition site and to increase space between the tag and cleavage site, allowing the enzyme greater ability to approach and cleave the protein.
Based on the structures presented in Fig. 7 , Ni-Gly0 would be expected to have the slowest rate of cleavage if dominated by steric hindrance and the rate would increase as a larger number of glycine residues were placed between the enzyme recognition sequence and the claMP Tag as a spacer. The trend of increasing cleavage rate with increasing number of spacer residues was observed for the constructs assembled with glycine spacers, with the exception of Gly0, which surprisingly has a more rapid rate of cleavage than Gly1-4, indicating that the amount of space is not the only significant influence on cleavage rate. It was expected that metal insertion would affect the structure between the two folded domains, causing the fusion protein to adopt a more protease-resistant conformation when the claMP Tag is loaded, as observed for constructs with 1-4 Gly spacer residues. Because the relative cleavage rate of Gly0 deviates from the expected trend, it is evident that in addition to steric hindrance adjacent or neighboring residues influence the rate of hydrolysis (Ewart et al., 1996; Supattapone et al., 2000) . This construct may have a conformation that is preferred by the enzyme, while those with spacer residues are more resistant to proteolysis. However, a notable chemical difference is that Gly0 has metal bound directly to the nitrogen of the peptide bond that is cleaved by the enzyme, and it is reasonable to anticipate direct metal coordination by the amide nitrogen of the cleaved peptide bond may promote hydrolysis (Fig. 7b) . Metal ions have chemical reactivity and can cause peptide bond breakage either through oxidation or hydrolysis (Allen and Campbell, 1996; Grant and Kassai, 2006) . Copper (II) binding within the hinge region of IgG1 monoclonal antibodies (mAbs) can lead to fragmentation, and in some cases, neighboring residues have been shown to alter the rate of hydrolysis of the peptide bond adjacent to the metal-binding site (Glover et al., 2015) . Nickel and other cationic transition metals are Lewis acids with high electron affinity, causing bond polarization and facilitating hydrolysis as well (Haas and Franz, 2009) . Metals also can promote hydrolysis by activating a water molecule that can be deprotonated by an adjacent basic side chain, mimicking natural metalloproteinases that use metals in their active site for the purpose of proteolytic hydrolysis (Humphreys et al., 2000; Andberg et al., 2007) . Importantly, because the nickel-bound claMP Tag and fusion protein is stable in the absence of Factor Xa, the presence of metal alone does not account for the observed increase in cleavage of the Gly0 construct. It is more likely that displacement of the proton from the backbone amide nitrogen by Ni(II) in the claMP Tag complex accelerates cleavage by altering the electronic properties of this peptide bond, making the enzymatic reaction more favorable. This could be accomplished by a preferred orientation that permits greater access to the recognition site or through the provision of a chemical moiety that facilitates the reaction or a combination of both. Because the adjacent residue is Gly in all of the constructs examined, the result is likely because another nearby residue in this construct presents a functional group in a structurally favorable position to facilitate more effectively the hydrolytic reaction. Although hydrolysis of the Gly0 construct occurs faster than the other claMP Tag constructs, Gly0 still offers significant protection compared to the control, indicating that inclusion of the metal-bound claMP Tag inhibits proteolysis and that the construct's stability can be tuned by placement and composition of neighboring residues.
In order for Factor Xa to attack the carbonyl of the stable amide bond in the peptide backbone of the substrate, residues within the substrate pocket of Factor Xa act as a general acid by hydrogen bonding to the carbonyl of the substrate, creating a more electrophilic carbon center for nucleophilic attack (Perona and Craik, 1995; Hedstrom, 2002) . Metal bound adjacent to the hydrolyzing peptide bond will increase the electron withdrawing effects, resulting in a more electrophilic center for nucleophilic attack by the serine residue, increasing the rate of peptide bond cleavage compared to when metal is not bound adjacently. This explanation would account for the anomalously fast rate of cleavage for Gly0, while steric occlusion explains the overall trend among the series of Glycontaining constructs with protonated rather than metal-bound adjacent nitrogen atoms. Once the kinked Ni-claMP Tag and the folded domains of the fusion partners are sufficiently separated in space from the protease recognition site, cleavage rates are expected to become more similar as more glycine residues are added. The rates of cleavage of Gly3 and Gly4 with and without metal are statistically identical. This result suggests that the metal-bound claMP Tag is directly responsible for inhibition when fewer than three residues separate the tag from the recognition site. Although a much larger series of variants would need to be examined to verify the mechanism, when three or more spacer residues are present, it seems that the size of the folded domains instead may limit diffusional access to the binding site to restrict approach by the enzyme.
Control of proteolysis is crucial and knowing both where and when cleavage occurs enables design of effective therapeutics. Prodrugs and antibody drug conjugates (ADCs) are designed to use proteolysis to their advantage. Such biologics aim to be stable and inaccessible to proteases in the serum yet degraded through proteolytic cleavage in the lysosomal compartment of the target cell to release the payload (Ducry and Stump, 2009; Law and Tung, 2009 ). The activity of Factor Xa was examined to gain an initial understanding of the inhibitory action of the claMP Tag when exposed to a serum protease, but during conditions of stress, such as disease, protease activity can increase. Diseased states, specifically tumor metastasis are typically associated with upregulation of proteases, which is of main concern when protection is needed until the biologic is internalized into the target cell (Duffy, 1992; Gabriel et al., 2011) . It is particularly important for ADCs to contain a stable linker to avoid proteolysis and release of the conjugated toxin before reaching the target because they can be in circulation for days (Teicher and Chari, 2011; Xu et al., 2011) . The site of release of the toxin will impact the toxicity profile and premature, untargeted release may cause unwanted toxicity (Lin and Tibbitts, 2012; Gébleux et al., 2015; Kamath and Iyer, 2015) . The ability to slow proteolysis in the serum by 3-fold or more would provide significant protection against premature release. As demonstrated in this proof of concept study, inclusion of the metal-bound claMP Tag can protect proteins from proteolytic degradation and by inference should decrease side effects due to premature release of a toxic payload in serum. ADCs target extracellular receptors and are taken up via endocytosis (Ritchie et al., 2013) . A commonly employed ADC delivery approach relies on enzymatic release of the toxic payload in lysosomes by cathepsin B (Ducry and Stump, 2010) . pH decreases with endocytosis and the acidic environment facilitates enzymatic cleavage. The claMP Tag has been demonstrated to be both stable and protease resistant in mildly basic conditions, including those that emulate serum (Mills and Laurence, 2015) . Importantly, metal release from the claMP Tag occurs solely below pH 7.00 in acidic conditions (Laurence et al., 2012) such that once a targeted molecule is directed to the lysosome (Ritchie et al., 2013) , cleavage would not be impeded because the tag would empty concomitantly. For practical reasons of analysis pH 8 was chosen for this study instead of serum pH with knowledge that the structure of the Ni-claMP complex remains unaltered above neutral pH up to at least pH 9 (Laurence et al., 2012) . Although actual enzyme rates of cleavage differ with pH, relative differences in cleavage of the constructs at pH 8.0 and 7.4 are expected to be similar and to follow the same trends. Previous stability characterization at pH 7.3 of claMPtagged protein showed the complex remains stable for at least 12 weeks (Mills and Laurence, 2015) . Examining proteolysis at a mildly basic pH where metal is retained and at acidic pH where metal is released allowed initial comparison of proteolysis among a series of claMP-tagged constructs within a simple system. Once a clinical candidate is identified, further experiments in serum would enable identification of all fragments and cleavage sites relevant for in vivo degradation.
Although all constructs with the metal-bound claMP Tag slowed proteolysis, it is evident that the specific amino acid sequence surrounding the tag affects cleavage. Further exploration of the adjacent sequence, specifically substitution of the glycine residues to more bulky groups, should be pursued to determine to what extent residue choice in neighboring positions offers greater protection. The presented data demonstrate clearly the claMP Tag reduces proteolysis at an existing recognition site. The claMP Tag not only provides protection from unwanted degradation, but this finding provides support for its use for the targeted delivery of metals. As such, further exploration of the amino acid residues surrounding the claMP Tag is warranted to determine the optimal sequence for resisting cleavage by Factor Xa and other serum proteases.
